Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the Vulva The routine use of large next-generation sequencing (NGS) pan-cancer panels is required to identify ...
Panel testing for genetic variants linked to more cancers is cost-effective than just testing or BRCA1/2 mutations, says a clinical director for a women's health company. If caught early, the survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results